Design and Evaluation of a CDSS for Drug Allergy Management Using LLMs and Pharmaceutical Data Integration
<|reference_start|>Design and Evaluation of a CDSS for Drug Allergy Management Using LLMs and Pharmaceutical Data Integration: Medication errors significantly threaten patient safety, leading to adverse drug events and substantial economic burdens on healthcare systems. Clinical Decision Support Systems (CDSSs) aimed at mitigating these errors often face limitations, including reliance on static databases and rule-based algorithms, which can result in high false alert rates and alert fatigue among clinicians. This paper introduces HELIOT, an innovative CDSS for drug allergy management, integrating Large Language Models (LLMs) with a comprehensive pharmaceutical data repository. HELIOT leverages advanced natural language processing capabilities to interpret complex medical texts and synthesize unstructured data, overcoming the limitations of traditional CDSSs. An empirical evaluation using a synthetic patient dataset and expert-verified ground truth demonstrates HELIOT's high accuracy, precision, recall, and F1 score, uniformly reaching 100\% across multiple experimental runs. The results underscore HELIOT's potential to enhance decision support in clinical settings, offering a scalable, efficient, and reliable solution for managing drug allergies.<|reference_end|>
@article{de vito2024design,
    title={Design and Evaluation of a CDSS for Drug Allergy Management Using LLMs
  and Pharmaceutical Data Integration},
    author={Gabriele De Vito, Filomena Ferrucci, Athanasios Angelakis},
    journal={arXiv preprint arXiv:2409.16395},
    year={2024},
    archivePrefix={arXiv},
    eprint={2409.16395},
    primaryClass={cs.AI}
}